Moderna’s cash flow issues are more immediate than those of its peers, so the new provision could have a greater impact on ...

Pfizer and Moderna will now include more information on the risk of myocarditis on their COVID-19 vaccine labels.

Retail investor chatter around vaccine makers Novavax, Moderna, and Pfizer rose on Wednesday, ahead of a closely watched CDC ...

Moderna shares surged 9.5% amid legal backlash against vaccine policy changes. Will it be a turning point for MRNA which is struggling with weaker sales?

The FDA has updated its warnings about potential cardiac risks associated with Pfizer and Moderna COVID-19 vaccines, ...

The Food and Drug Administration has required Pfizer and Moderna to expand the warning labels on their mRNA COVID-19 vaccines ...

The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to ...

FDA vaccine head Vinay Prasad restricted Moderna and Novavax COVID vaccines to high-risk groups, overriding staff advice amid ...

Federal documents show he disagreed with conclusions the benefits outweighed the risk of side effects, which are rare.

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

The phase three study data clears the path forward for Moderna’s combination jab targeting Covid-19 and influenza.

The Food and Drug Administration has updated its warning labels for the Pfizer and Moderna COVID-19 vaccines, expanding ...